JP2001081019A - Anticariogenic agent and composition for oral cavity containing the same - Google Patents
Anticariogenic agent and composition for oral cavity containing the sameInfo
- Publication number
- JP2001081019A JP2001081019A JP25994699A JP25994699A JP2001081019A JP 2001081019 A JP2001081019 A JP 2001081019A JP 25994699 A JP25994699 A JP 25994699A JP 25994699 A JP25994699 A JP 25994699A JP 2001081019 A JP2001081019 A JP 2001081019A
- Authority
- JP
- Japan
- Prior art keywords
- yucca
- sodium
- extract
- extraction
- anticariogenic agent
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 239000000203 mixture Substances 0.000 title claims abstract description 29
- 230000000170 anti-cariogenic effect Effects 0.000 title claims abstract description 12
- 210000000214 mouth Anatomy 0.000 title abstract description 4
- 239000001726 jatropha manihot extract Substances 0.000 claims abstract description 24
- 229940106668 yucca extract Drugs 0.000 claims abstract description 24
- 239000004075 cariostatic agent Substances 0.000 claims description 7
- 239000004091 cariogenic agent Substances 0.000 claims description 6
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 abstract description 18
- 235000004552 Yucca aloifolia Nutrition 0.000 abstract description 17
- 239000001653 FEMA 3120 Substances 0.000 abstract description 16
- 235000012044 Yucca brevifolia Nutrition 0.000 abstract description 16
- 235000017049 Yucca glauca Nutrition 0.000 abstract description 16
- 239000003795 chemical substances by application Substances 0.000 abstract description 13
- 238000000605 extraction Methods 0.000 abstract description 12
- 241000194019 Streptococcus mutans Species 0.000 abstract description 9
- 230000007505 plaque formation Effects 0.000 abstract description 7
- 230000002401 inhibitory effect Effects 0.000 abstract description 6
- 239000007788 liquid Substances 0.000 abstract description 5
- 239000003960 organic solvent Substances 0.000 abstract description 5
- 239000007787 solid Substances 0.000 abstract description 5
- 239000003814 drug Substances 0.000 abstract description 4
- 230000001580 bacterial effect Effects 0.000 abstract description 2
- 229940079593 drug Drugs 0.000 abstract description 2
- 241001532059 Yucca Species 0.000 abstract 1
- 239000000463 material Substances 0.000 abstract 1
- PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 description 18
- 244000295923 Yucca aloifolia Species 0.000 description 16
- VYPSYNLAJGMNEJ-UHFFFAOYSA-N Silicium dioxide Chemical compound O=[Si]=O VYPSYNLAJGMNEJ-UHFFFAOYSA-N 0.000 description 14
- 239000008213 purified water Substances 0.000 description 11
- 239000000606 toothpaste Substances 0.000 description 11
- -1 alkali metal alginate Chemical class 0.000 description 10
- 229940034610 toothpaste Drugs 0.000 description 10
- DNIAPMSPPWPWGF-UHFFFAOYSA-N Propylene glycol Chemical compound CC(O)CO DNIAPMSPPWPWGF-UHFFFAOYSA-N 0.000 description 9
- 235000011187 glycerol Nutrition 0.000 description 9
- 238000007796 conventional method Methods 0.000 description 8
- 238000009472 formulation Methods 0.000 description 8
- 238000002360 preparation method Methods 0.000 description 8
- 239000001768 carboxy methyl cellulose Substances 0.000 description 7
- 208000002925 dental caries Diseases 0.000 description 7
- 239000000284 extract Substances 0.000 description 7
- VTYYLEPIZMXCLO-UHFFFAOYSA-L Calcium carbonate Chemical compound [Ca+2].[O-]C([O-])=O VTYYLEPIZMXCLO-UHFFFAOYSA-L 0.000 description 6
- DPXJVFZANSGRMM-UHFFFAOYSA-N acetic acid;2,3,4,5,6-pentahydroxyhexanal;sodium Chemical compound [Na].CC(O)=O.OCC(O)C(O)C(O)C(O)C=O DPXJVFZANSGRMM-UHFFFAOYSA-N 0.000 description 6
- 230000000694 effects Effects 0.000 description 6
- 239000002324 mouth wash Substances 0.000 description 6
- 229940051866 mouthwash Drugs 0.000 description 6
- 239000002994 raw material Substances 0.000 description 6
- 235000019812 sodium carboxymethyl cellulose Nutrition 0.000 description 6
- 229920001027 sodium carboxymethylcellulose Polymers 0.000 description 6
- 238000012360 testing method Methods 0.000 description 6
- MPDGHEJMBKOTSU-YKLVYJNSSA-N 18beta-glycyrrhetic acid Chemical class C([C@H]1C2=CC(=O)[C@H]34)[C@@](C)(C(O)=O)CC[C@]1(C)CC[C@@]2(C)[C@]4(C)CC[C@@H]1[C@]3(C)CC[C@H](O)C1(C)C MPDGHEJMBKOTSU-YKLVYJNSSA-N 0.000 description 5
- FBPFZTCFMRRESA-JGWLITMVSA-N D-glucitol Chemical compound OC[C@H](O)[C@@H](O)[C@H](O)[C@H](O)CO FBPFZTCFMRRESA-JGWLITMVSA-N 0.000 description 5
- DBMJMQXJHONAFJ-UHFFFAOYSA-M Sodium laurylsulphate Chemical compound [Na+].CCCCCCCCCCCCOS([O-])(=O)=O DBMJMQXJHONAFJ-UHFFFAOYSA-M 0.000 description 5
- 239000000551 dentifrice Substances 0.000 description 5
- 238000000034 method Methods 0.000 description 5
- 239000002304 perfume Substances 0.000 description 5
- 235000019333 sodium laurylsulphate Nutrition 0.000 description 5
- 239000000243 solution Substances 0.000 description 5
- PUPZLCDOIYMWBV-UHFFFAOYSA-N (+/-)-1,3-Butanediol Chemical compound CC(O)CCO PUPZLCDOIYMWBV-UHFFFAOYSA-N 0.000 description 4
- 241000894006 Bacteria Species 0.000 description 4
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 4
- 229920001503 Glucan Polymers 0.000 description 4
- 239000008186 active pharmaceutical agent Substances 0.000 description 4
- 235000014113 dietary fatty acids Nutrition 0.000 description 4
- NUVBSKCKDOMJSU-UHFFFAOYSA-N ethylparaben Chemical compound CCOC(=O)C1=CC=C(O)C=C1 NUVBSKCKDOMJSU-UHFFFAOYSA-N 0.000 description 4
- 239000000194 fatty acid Substances 0.000 description 4
- 229930195729 fatty acid Natural products 0.000 description 4
- 239000002904 solvent Substances 0.000 description 4
- HEBKCHPVOIAQTA-SCDXWVJYSA-N xylitol Chemical compound OC[C@H](O)[C@@H](O)[C@H](O)CO HEBKCHPVOIAQTA-SCDXWVJYSA-N 0.000 description 4
- CSCPPACGZOOCGX-UHFFFAOYSA-N Acetone Chemical compound CC(C)=O CSCPPACGZOOCGX-UHFFFAOYSA-N 0.000 description 3
- LYCAIKOWRPUZTN-UHFFFAOYSA-N Ethylene glycol Chemical compound OCCO LYCAIKOWRPUZTN-UHFFFAOYSA-N 0.000 description 3
- OKKJLVBELUTLKV-UHFFFAOYSA-N Methanol Chemical compound OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 description 3
- 229920003171 Poly (ethylene oxide) Polymers 0.000 description 3
- HEMHJVSKTPXQMS-UHFFFAOYSA-M Sodium hydroxide Chemical compound [OH-].[Na+] HEMHJVSKTPXQMS-UHFFFAOYSA-M 0.000 description 3
- 229930006000 Sucrose Natural products 0.000 description 3
- CZMRCDWAGMRECN-UGDNZRGBSA-N Sucrose Chemical compound O[C@H]1[C@H](O)[C@@H](CO)O[C@@]1(CO)O[C@@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O1 CZMRCDWAGMRECN-UGDNZRGBSA-N 0.000 description 3
- GWEVSGVZZGPLCZ-UHFFFAOYSA-N Titan oxide Chemical compound O=[Ti]=O GWEVSGVZZGPLCZ-UHFFFAOYSA-N 0.000 description 3
- TVXBFESIOXBWNM-UHFFFAOYSA-N Xylitol Natural products OCCC(O)C(O)C(O)CCO TVXBFESIOXBWNM-UHFFFAOYSA-N 0.000 description 3
- 239000002253 acid Substances 0.000 description 3
- 239000004480 active ingredient Substances 0.000 description 3
- 239000007621 bhi medium Substances 0.000 description 3
- 239000011230 binding agent Substances 0.000 description 3
- 230000015572 biosynthetic process Effects 0.000 description 3
- 229910000019 calcium carbonate Inorganic materials 0.000 description 3
- 235000010418 carrageenan Nutrition 0.000 description 3
- 239000000679 carrageenan Substances 0.000 description 3
- 229920001525 carrageenan Polymers 0.000 description 3
- 229940113118 carrageenan Drugs 0.000 description 3
- 239000004359 castor oil Substances 0.000 description 3
- 235000019438 castor oil Nutrition 0.000 description 3
- 229940112822 chewing gum Drugs 0.000 description 3
- 235000015218 chewing gum Nutrition 0.000 description 3
- KRKNYBCHXYNGOX-UHFFFAOYSA-N citric acid Chemical compound OC(=O)CC(O)(C(O)=O)CC(O)=O KRKNYBCHXYNGOX-UHFFFAOYSA-N 0.000 description 3
- ZEMPKEQAKRGZGQ-XOQCFJPHSA-N glycerol triricinoleate Natural products CCCCCC[C@@H](O)CC=CCCCCCCCC(=O)OC[C@@H](COC(=O)CCCCCCCC=CC[C@@H](O)CCCCCC)OC(=O)CCCCCCCC=CC[C@H](O)CCCCCC ZEMPKEQAKRGZGQ-XOQCFJPHSA-N 0.000 description 3
- 230000005764 inhibitory process Effects 0.000 description 3
- HEBKCHPVOIAQTA-UHFFFAOYSA-N meso ribitol Natural products OCC(O)C(O)C(O)CO HEBKCHPVOIAQTA-UHFFFAOYSA-N 0.000 description 3
- OSWPMRLSEDHDFF-UHFFFAOYSA-N methyl salicylate Chemical compound COC(=O)C1=CC=CC=C1O OSWPMRLSEDHDFF-UHFFFAOYSA-N 0.000 description 3
- 235000013772 propylene glycol Nutrition 0.000 description 3
- 239000000377 silicon dioxide Substances 0.000 description 3
- 239000005720 sucrose Substances 0.000 description 3
- 239000000811 xylitol Substances 0.000 description 3
- 235000010447 xylitol Nutrition 0.000 description 3
- 229960002675 xylitol Drugs 0.000 description 3
- UHVMMEOXYDMDKI-JKYCWFKZSA-L zinc;1-(5-cyanopyridin-2-yl)-3-[(1s,2s)-2-(6-fluoro-2-hydroxy-3-propanoylphenyl)cyclopropyl]urea;diacetate Chemical compound [Zn+2].CC([O-])=O.CC([O-])=O.CCC(=O)C1=CC=C(F)C([C@H]2[C@H](C2)NC(=O)NC=2N=CC(=CC=2)C#N)=C1O UHVMMEOXYDMDKI-JKYCWFKZSA-L 0.000 description 3
- 229940058015 1,3-butylene glycol Drugs 0.000 description 2
- XGRSAFKZAGGXJV-UHFFFAOYSA-N 3-azaniumyl-3-cyclohexylpropanoate Chemical compound OC(=O)CC(N)C1CCCCC1 XGRSAFKZAGGXJV-UHFFFAOYSA-N 0.000 description 2
- 208000002064 Dental Plaque Diseases 0.000 description 2
- 239000000253 Denture Cleanser Substances 0.000 description 2
- 108090000790 Enzymes Proteins 0.000 description 2
- 102000004190 Enzymes Human genes 0.000 description 2
- 102000000340 Glucosyltransferases Human genes 0.000 description 2
- 108010055629 Glucosyltransferases Proteins 0.000 description 2
- MPDGHEJMBKOTSU-UHFFFAOYSA-N Glycyrrhetinsaeure Natural products C12C(=O)C=C3C4CC(C)(C(O)=O)CCC4(C)CCC3(C)C1(C)CCC1C2(C)CCC(O)C1(C)C MPDGHEJMBKOTSU-UHFFFAOYSA-N 0.000 description 2
- 108010014251 Muramidase Proteins 0.000 description 2
- 102000016943 Muramidase Human genes 0.000 description 2
- 108010062010 N-Acetylmuramoyl-L-alanine Amidase Proteins 0.000 description 2
- CDBYLPFSWZWCQE-UHFFFAOYSA-L Sodium Carbonate Chemical compound [Na+].[Na+].[O-]C([O-])=O CDBYLPFSWZWCQE-UHFFFAOYSA-L 0.000 description 2
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 description 2
- 241000194017 Streptococcus Species 0.000 description 2
- XEFQLINVKFYRCS-UHFFFAOYSA-N Triclosan Chemical compound OC1=CC(Cl)=CC=C1OC1=CC=C(Cl)C=C1Cl XEFQLINVKFYRCS-UHFFFAOYSA-N 0.000 description 2
- 235000004584 Yucca mohavensis Nutrition 0.000 description 2
- 230000001464 adherent effect Effects 0.000 description 2
- WNROFYMDJYEPJX-UHFFFAOYSA-K aluminium hydroxide Chemical compound [OH-].[OH-].[OH-].[Al+3] WNROFYMDJYEPJX-UHFFFAOYSA-K 0.000 description 2
- CUFNKYGDVFVPHO-UHFFFAOYSA-N azulene Chemical compound C1=CC=CC2=CC=CC2=C1 CUFNKYGDVFVPHO-UHFFFAOYSA-N 0.000 description 2
- WPYMKLBDIGXBTP-UHFFFAOYSA-N benzoic acid Chemical compound OC(=O)C1=CC=CC=C1 WPYMKLBDIGXBTP-UHFFFAOYSA-N 0.000 description 2
- 235000019437 butane-1,3-diol Nutrition 0.000 description 2
- XAAHAAMILDNBPS-UHFFFAOYSA-L calcium hydrogenphosphate dihydrate Chemical compound O.O.[Ca+2].OP([O-])([O-])=O XAAHAAMILDNBPS-UHFFFAOYSA-L 0.000 description 2
- ULDHMXUKGWMISQ-UHFFFAOYSA-N carvone Chemical compound CC(=C)C1CC=C(C)C(=O)C1 ULDHMXUKGWMISQ-UHFFFAOYSA-N 0.000 description 2
- 229960001927 cetylpyridinium chloride Drugs 0.000 description 2
- YMKDRGPMQRFJGP-UHFFFAOYSA-M cetylpyridinium chloride Chemical compound [Cl-].CCCCCCCCCCCCCCCC[N+]1=CC=CC=C1 YMKDRGPMQRFJGP-UHFFFAOYSA-M 0.000 description 2
- 235000019700 dicalcium phosphate Nutrition 0.000 description 2
- 229960003720 enoxolone Drugs 0.000 description 2
- 229940088598 enzyme Drugs 0.000 description 2
- 235000010228 ethyl p-hydroxybenzoate Nutrition 0.000 description 2
- 239000004403 ethyl p-hydroxybenzoate Substances 0.000 description 2
- RRAFCDWBNXTKKO-UHFFFAOYSA-N eugenol Chemical compound COC1=CC(CC=C)=CC=C1O RRAFCDWBNXTKKO-UHFFFAOYSA-N 0.000 description 2
- 239000000796 flavoring agent Substances 0.000 description 2
- 235000019634 flavors Nutrition 0.000 description 2
- 229920000591 gum Polymers 0.000 description 2
- 239000003112 inhibitor Substances 0.000 description 2
- 239000004325 lysozyme Substances 0.000 description 2
- 235000010335 lysozyme Nutrition 0.000 description 2
- 229960000274 lysozyme Drugs 0.000 description 2
- 239000006072 paste Substances 0.000 description 2
- FGIUAXJPYTZDNR-UHFFFAOYSA-N potassium nitrate Chemical compound [K+].[O-][N+]([O-])=O FGIUAXJPYTZDNR-UHFFFAOYSA-N 0.000 description 2
- 239000000843 powder Substances 0.000 description 2
- 239000011734 sodium Substances 0.000 description 2
- 229910052708 sodium Inorganic materials 0.000 description 2
- PUZPDOWCWNUUKD-UHFFFAOYSA-M sodium fluoride Chemical compound [F-].[Na+] PUZPDOWCWNUUKD-UHFFFAOYSA-M 0.000 description 2
- KSAVQLQVUXSOCR-UHFFFAOYSA-M sodium lauroyl sarcosinate Chemical compound [Na+].CCCCCCCCCCCC(=O)N(C)CC([O-])=O KSAVQLQVUXSOCR-UHFFFAOYSA-M 0.000 description 2
- 229960004711 sodium monofluorophosphate Drugs 0.000 description 2
- 235000000346 sugar Nutrition 0.000 description 2
- 239000012085 test solution Substances 0.000 description 2
- MGSRCZKZVOBKFT-UHFFFAOYSA-N thymol Chemical compound CC(C)C1=CC=C(C)C=C1O MGSRCZKZVOBKFT-UHFFFAOYSA-N 0.000 description 2
- RUVINXPYWBROJD-ONEGZZNKSA-N trans-anethole Chemical compound COC1=CC=C(\C=C\C)C=C1 RUVINXPYWBROJD-ONEGZZNKSA-N 0.000 description 2
- 229960003500 triclosan Drugs 0.000 description 2
- 235000010493 xanthan gum Nutrition 0.000 description 2
- 239000000230 xanthan gum Substances 0.000 description 2
- 229920001285 xanthan gum Polymers 0.000 description 2
- 229940082509 xanthan gum Drugs 0.000 description 2
- NOOLISFMXDJSKH-KXUCPTDWSA-N (-)-Menthol Chemical compound CC(C)[C@@H]1CC[C@@H](C)C[C@H]1O NOOLISFMXDJSKH-KXUCPTDWSA-N 0.000 description 1
- FTLYMKDSHNWQKD-UHFFFAOYSA-N (2,4,5-trichlorophenyl)boronic acid Chemical compound OB(O)C1=CC(Cl)=C(Cl)C=C1Cl FTLYMKDSHNWQKD-UHFFFAOYSA-N 0.000 description 1
- QYIXCDOBOSTCEI-QCYZZNICSA-N (5alpha)-cholestan-3beta-ol Chemical compound C([C@@H]1CC2)[C@@H](O)CC[C@]1(C)[C@@H]1[C@@H]2[C@@H]2CC[C@H]([C@H](C)CCCC(C)C)[C@@]2(C)CC1 QYIXCDOBOSTCEI-QCYZZNICSA-N 0.000 description 1
- NWUYHJFMYQTDRP-UHFFFAOYSA-N 1,2-bis(ethenyl)benzene;1-ethenyl-2-ethylbenzene;styrene Chemical compound C=CC1=CC=CC=C1.CCC1=CC=CC=C1C=C.C=CC1=CC=CC=C1C=C NWUYHJFMYQTDRP-UHFFFAOYSA-N 0.000 description 1
- LDVVTQMJQSCDMK-UHFFFAOYSA-N 1,3-dihydroxypropan-2-yl formate Chemical compound OCC(CO)OC=O LDVVTQMJQSCDMK-UHFFFAOYSA-N 0.000 description 1
- PQUXFUBNSYCQAL-UHFFFAOYSA-N 1-(2,3-difluorophenyl)ethanone Chemical compound CC(=O)C1=CC=CC(F)=C1F PQUXFUBNSYCQAL-UHFFFAOYSA-N 0.000 description 1
- OOSZCNKVJAVHJI-UHFFFAOYSA-N 1-[(4-fluorophenyl)methyl]piperazine Chemical compound C1=CC(F)=CC=C1CN1CCNCC1 OOSZCNKVJAVHJI-UHFFFAOYSA-N 0.000 description 1
- IXPNQXFRVYWDDI-UHFFFAOYSA-N 1-methyl-2,4-dioxo-1,3-diazinane-5-carboximidamide Chemical compound CN1CC(C(N)=N)C(=O)NC1=O IXPNQXFRVYWDDI-UHFFFAOYSA-N 0.000 description 1
- YOBWBLFILQYRFY-UHFFFAOYSA-N 2-hexadecylpyridine;hydrochloride Chemical compound [Cl-].CCCCCCCCCCCCCCCCC1=CC=CC=[NH+]1 YOBWBLFILQYRFY-UHFFFAOYSA-N 0.000 description 1
- SQVHRJXGOIGDTD-UHFFFAOYSA-N 4-(3-hydroxypropyl)benzoic acid Chemical compound OCCCC1=CC=C(C(O)=O)C=C1 SQVHRJXGOIGDTD-UHFFFAOYSA-N 0.000 description 1
- KGKRDKISRBUFHF-UHFFFAOYSA-N 4-(4-hydroxybutyl)benzoic acid Chemical compound OCCCCC1=CC=C(C(O)=O)C=C1 KGKRDKISRBUFHF-UHFFFAOYSA-N 0.000 description 1
- IJALWSVNUBBQRA-UHFFFAOYSA-N 4-Isopropyl-3-methylphenol Chemical compound CC(C)C1=CC=C(O)C=C1C IJALWSVNUBBQRA-UHFFFAOYSA-N 0.000 description 1
- DDFHBQSCUXNBSA-UHFFFAOYSA-N 5-(5-carboxythiophen-2-yl)thiophene-2-carboxylic acid Chemical compound S1C(C(=O)O)=CC=C1C1=CC=C(C(O)=O)S1 DDFHBQSCUXNBSA-UHFFFAOYSA-N 0.000 description 1
- SLXKOJJOQWFEFD-UHFFFAOYSA-N 6-aminohexanoic acid Chemical compound NCCCCCC(O)=O SLXKOJJOQWFEFD-UHFFFAOYSA-N 0.000 description 1
- 244000215068 Acacia senegal Species 0.000 description 1
- 239000004382 Amylase Substances 0.000 description 1
- 102000013142 Amylases Human genes 0.000 description 1
- 108010065511 Amylases Proteins 0.000 description 1
- 239000005711 Benzoic acid Substances 0.000 description 1
- 229920002134 Carboxymethyl cellulose Polymers 0.000 description 1
- 239000005973 Carvone Substances 0.000 description 1
- NPBVQXIMTZKSBA-UHFFFAOYSA-N Chavibetol Natural products COC1=CC=C(CC=C)C=C1O NPBVQXIMTZKSBA-UHFFFAOYSA-N 0.000 description 1
- GHXZTYHSJHQHIJ-UHFFFAOYSA-N Chlorhexidine Chemical class C=1C=C(Cl)C=CC=1NC(N)=NC(N)=NCCCCCCN=C(N)N=C(N)NC1=CC=C(Cl)C=C1 GHXZTYHSJHQHIJ-UHFFFAOYSA-N 0.000 description 1
- VEXZGXHMUGYJMC-UHFFFAOYSA-M Chloride anion Chemical compound [Cl-] VEXZGXHMUGYJMC-UHFFFAOYSA-M 0.000 description 1
- 244000146493 Cryptotaenia japonica Species 0.000 description 1
- 235000004035 Cryptotaenia japonica Nutrition 0.000 description 1
- 240000004244 Cucurbita moschata Species 0.000 description 1
- 235000009854 Cucurbita moschata Nutrition 0.000 description 1
- UDIPTWFVPPPURJ-UHFFFAOYSA-M Cyclamate Chemical compound [Na+].[O-]S(=O)(=O)NC1CCCCC1 UDIPTWFVPPPURJ-UHFFFAOYSA-M 0.000 description 1
- FBPFZTCFMRRESA-FSIIMWSLSA-N D-Glucitol Natural products OC[C@H](O)[C@H](O)[C@@H](O)[C@H](O)CO FBPFZTCFMRRESA-FSIIMWSLSA-N 0.000 description 1
- ZAKOWWREFLAJOT-CEFNRUSXSA-N D-alpha-tocopherylacetate Chemical compound CC(=O)OC1=C(C)C(C)=C2O[C@@](CCC[C@H](C)CCC[C@H](C)CCCC(C)C)(C)CCC2=C1C ZAKOWWREFLAJOT-CEFNRUSXSA-N 0.000 description 1
- 239000011626 DL-alpha-tocopherylacetate Substances 0.000 description 1
- 235000001809 DL-alpha-tocopherylacetate Nutrition 0.000 description 1
- 229920002307 Dextran Polymers 0.000 description 1
- 108010001682 Dextranase Proteins 0.000 description 1
- 241000196324 Embryophyta Species 0.000 description 1
- 101000925662 Enterobacteria phage PRD1 Endolysin Proteins 0.000 description 1
- 239000005770 Eugenol Substances 0.000 description 1
- 240000006927 Foeniculum vulgare Species 0.000 description 1
- 235000004204 Foeniculum vulgare Nutrition 0.000 description 1
- 239000005715 Fructose Substances 0.000 description 1
- 229930091371 Fructose Natural products 0.000 description 1
- RFSUNEUAIZKAJO-ARQDHWQXSA-N Fructose Chemical compound OC[C@H]1O[C@](O)(CO)[C@@H](O)[C@@H]1O RFSUNEUAIZKAJO-ARQDHWQXSA-N 0.000 description 1
- 239000004378 Glycyrrhizin Substances 0.000 description 1
- BIVBRWYINDPWKA-VLQRKCJKSA-L Glycyrrhizinate dipotassium Chemical compound [K+].[K+].O([C@@H]1[C@@H](O)[C@H](O)[C@H](O[C@@H]1O[C@H]1CC[C@]2(C)[C@H]3C(=O)C=C4[C@@H]5C[C@](C)(CC[C@@]5(CC[C@@]4(C)[C@]3(C)CC[C@H]2C1(C)C)C)C(O)=O)C([O-])=O)[C@@H]1O[C@H](C([O-])=O)[C@@H](O)[C@H](O)[C@H]1O BIVBRWYINDPWKA-VLQRKCJKSA-L 0.000 description 1
- 229920000084 Gum arabic Polymers 0.000 description 1
- 229920000569 Gum karaya Polymers 0.000 description 1
- 241001437371 Hesperoyucca peninsularis Species 0.000 description 1
- 240000003372 Hesperoyucca whipplei Species 0.000 description 1
- 235000008705 Hesperoyucca whipplei Nutrition 0.000 description 1
- VEXZGXHMUGYJMC-UHFFFAOYSA-N Hydrochloric acid Chemical compound Cl VEXZGXHMUGYJMC-UHFFFAOYSA-N 0.000 description 1
- DGAQECJNVWCQMB-PUAWFVPOSA-M Ilexoside XXIX Chemical compound C[C@@H]1CC[C@@]2(CC[C@@]3(C(=CC[C@H]4[C@]3(CC[C@@H]5[C@@]4(CC[C@@H](C5(C)C)OS(=O)(=O)[O-])C)C)[C@@H]2[C@]1(C)O)C)C(=O)O[C@H]6[C@@H]([C@H]([C@@H]([C@H](O6)CO)O)O)O.[Na+] DGAQECJNVWCQMB-PUAWFVPOSA-M 0.000 description 1
- 235000019501 Lemon oil Nutrition 0.000 description 1
- 240000003183 Manihot esculenta Species 0.000 description 1
- 235000019502 Orange oil Nutrition 0.000 description 1
- 108091005804 Peptidases Proteins 0.000 description 1
- 239000002202 Polyethylene glycol Substances 0.000 description 1
- 229920001214 Polysorbate 60 Polymers 0.000 description 1
- 239000004372 Polyvinyl alcohol Substances 0.000 description 1
- HDSBZMRLPLPFLQ-UHFFFAOYSA-N Propylene glycol alginate Chemical compound OC1C(O)C(OC)OC(C(O)=O)C1OC1C(O)C(O)C(C)C(C(=O)OCC(C)O)O1 HDSBZMRLPLPFLQ-UHFFFAOYSA-N 0.000 description 1
- 239000004365 Protease Substances 0.000 description 1
- UVMRYBDEERADNV-UHFFFAOYSA-N Pseudoeugenol Natural products COC1=CC(C(C)=C)=CC=C1O UVMRYBDEERADNV-UHFFFAOYSA-N 0.000 description 1
- QNVSXXGDAPORNA-UHFFFAOYSA-N Resveratrol Natural products OC1=CC=CC(C=CC=2C=C(O)C(O)=CC=2)=C1 QNVSXXGDAPORNA-UHFFFAOYSA-N 0.000 description 1
- 102100037486 Reverse transcriptase/ribonuclease H Human genes 0.000 description 1
- 229920002125 Sokalan® Polymers 0.000 description 1
- UEDUENGHJMELGK-HYDKPPNVSA-N Stevioside Chemical compound O([C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@H]1O[C@]12C(=C)C[C@@]3(C1)CC[C@@H]1[C@@](C)(CCC[C@]1([C@@H]3CC2)C)C(=O)O[C@H]1[C@@H]([C@@H](O)[C@H](O)[C@@H](CO)O1)O)[C@@H]1O[C@H](CO)[C@@H](O)[C@H](O)[C@H]1O UEDUENGHJMELGK-HYDKPPNVSA-N 0.000 description 1
- 239000005844 Thymol Substances 0.000 description 1
- 229920001615 Tragacanth Polymers 0.000 description 1
- LUKBXSAWLPMMSZ-OWOJBTEDSA-N Trans-resveratrol Chemical compound C1=CC(O)=CC=C1\C=C\C1=CC(O)=CC(O)=C1 LUKBXSAWLPMMSZ-OWOJBTEDSA-N 0.000 description 1
- 241000180519 Yucca arizonica Species 0.000 description 1
- 241001532060 Yucca elata Species 0.000 description 1
- 244000222678 Yucca mohavensis Species 0.000 description 1
- 241000814162 Yucca recurvifolia Species 0.000 description 1
- 244000110633 Yucca schidigera Species 0.000 description 1
- 235000006012 Yucca schidigera Nutrition 0.000 description 1
- 244000163876 Yucca smalliana Species 0.000 description 1
- 235000004649 Yucca smalliana Nutrition 0.000 description 1
- 239000003082 abrasive agent Substances 0.000 description 1
- 238000002835 absorbance Methods 0.000 description 1
- 235000010489 acacia gum Nutrition 0.000 description 1
- 239000000205 acacia gum Substances 0.000 description 1
- 150000007513 acids Chemical class 0.000 description 1
- 150000001298 alcohols Chemical class 0.000 description 1
- 229940072056 alginate Drugs 0.000 description 1
- 235000010443 alginic acid Nutrition 0.000 description 1
- 229920000615 alginic acid Polymers 0.000 description 1
- 229910052783 alkali metal Inorganic materials 0.000 description 1
- QYIXCDOBOSTCEI-UHFFFAOYSA-N alpha-cholestanol Natural products C1CC2CC(O)CCC2(C)C2C1C1CCC(C(C)CCCC(C)C)C1(C)CC2 QYIXCDOBOSTCEI-UHFFFAOYSA-N 0.000 description 1
- 229910052782 aluminium Inorganic materials 0.000 description 1
- XAGFODPZIPBFFR-UHFFFAOYSA-N aluminium Chemical compound [Al] XAGFODPZIPBFFR-UHFFFAOYSA-N 0.000 description 1
- 229910000323 aluminium silicate Inorganic materials 0.000 description 1
- 229960002684 aminocaproic acid Drugs 0.000 description 1
- 235000019418 amylase Nutrition 0.000 description 1
- 229940011037 anethole Drugs 0.000 description 1
- 239000003242 anti bacterial agent Substances 0.000 description 1
- 230000002272 anti-calculus Effects 0.000 description 1
- 239000000305 astragalus gummifer gum Substances 0.000 description 1
- 239000002585 base Substances 0.000 description 1
- 235000010233 benzoic acid Nutrition 0.000 description 1
- 229920001400 block copolymer Polymers 0.000 description 1
- 238000009835 boiling Methods 0.000 description 1
- 210000004556 brain Anatomy 0.000 description 1
- JUNWLZAGQLJVLR-UHFFFAOYSA-J calcium diphosphate Chemical compound [Ca+2].[Ca+2].[O-]P([O-])(=O)OP([O-])([O-])=O JUNWLZAGQLJVLR-UHFFFAOYSA-J 0.000 description 1
- FUFJGUQYACFECW-UHFFFAOYSA-L calcium hydrogenphosphate Chemical compound [Ca+2].OP([O-])([O-])=O FUFJGUQYACFECW-UHFFFAOYSA-L 0.000 description 1
- 229940043256 calcium pyrophosphate Drugs 0.000 description 1
- 235000010948 carboxy methyl cellulose Nutrition 0.000 description 1
- 239000008112 carboxymethyl-cellulose Substances 0.000 description 1
- 229940105329 carboxymethylcellulose Drugs 0.000 description 1
- 230000001013 cariogenic effect Effects 0.000 description 1
- 229920002678 cellulose Polymers 0.000 description 1
- 239000001913 cellulose Substances 0.000 description 1
- 229930002875 chlorophyll Natural products 0.000 description 1
- 235000019804 chlorophyll Nutrition 0.000 description 1
- ATNHDLDRLWWWCB-AENOIHSZSA-M chlorophyll a Chemical compound C1([C@@H](C(=O)OC)C(=O)C2=C3C)=C2N2C3=CC(C(CC)=C3C)=[N+]4C3=CC3=C(C=C)C(C)=C5N3[Mg-2]42[N+]2=C1[C@@H](CCC(=O)OC\C=C(/C)CCC[C@H](C)CCC[C@H](C)CCCC(C)C)[C@H](C)C2=C5 ATNHDLDRLWWWCB-AENOIHSZSA-M 0.000 description 1
- 239000010634 clove oil Substances 0.000 description 1
- 235000009508 confectionery Nutrition 0.000 description 1
- HWDGVJUIHRPKFR-UHFFFAOYSA-I copper;trisodium;18-(2-carboxylatoethyl)-20-(carboxylatomethyl)-12-ethenyl-7-ethyl-3,8,13,17-tetramethyl-17,18-dihydroporphyrin-21,23-diide-2-carboxylate Chemical compound [Na+].[Na+].[Na+].[Cu+2].N1=C(C(CC([O-])=O)=C2C(C(C)C(C=C3C(=C(C=C)C(=C4)[N-]3)C)=N2)CCC([O-])=O)C(=C([O-])[O-])C(C)=C1C=C1C(CC)=C(C)C4=N1 HWDGVJUIHRPKFR-UHFFFAOYSA-I 0.000 description 1
- 229910002026 crystalline silica Inorganic materials 0.000 description 1
- 238000012258 culturing Methods 0.000 description 1
- 239000000625 cyclamic acid and its Na and Ca salt Substances 0.000 description 1
- 239000011928 denatured alcohol Substances 0.000 description 1
- 210000003298 dental enamel Anatomy 0.000 description 1
- 235000019821 dicalcium diphosphate Nutrition 0.000 description 1
- HNPSIPDUKPIQMN-UHFFFAOYSA-N dioxosilane;oxo(oxoalumanyloxy)alumane Chemical compound O=[Si]=O.O=[Al]O[Al]=O HNPSIPDUKPIQMN-UHFFFAOYSA-N 0.000 description 1
- 229940101029 dipotassium glycyrrhizinate Drugs 0.000 description 1
- FXNRKXSSLJKNGH-UHFFFAOYSA-L dipotassium;fluoro-dioxido-oxo-$l^{5}-phosphane Chemical compound [K+].[K+].[O-]P([O-])(F)=O FXNRKXSSLJKNGH-UHFFFAOYSA-L 0.000 description 1
- GVGUFUZHNYFZLC-UHFFFAOYSA-N dodecyl benzenesulfonate;sodium Chemical compound [Na].CCCCCCCCCCCCOS(=O)(=O)C1=CC=CC=C1 GVGUFUZHNYFZLC-UHFFFAOYSA-N 0.000 description 1
- BEFDCLMNVWHSGT-UHFFFAOYSA-N ethenylcyclopentane Chemical compound C=CC1CCCC1 BEFDCLMNVWHSGT-UHFFFAOYSA-N 0.000 description 1
- 125000001495 ethyl group Chemical group [H]C([H])([H])C([H])([H])* 0.000 description 1
- 239000010642 eucalyptus oil Substances 0.000 description 1
- 229940044949 eucalyptus oil Drugs 0.000 description 1
- 229960002217 eugenol Drugs 0.000 description 1
- 108010000165 exo-1,3-alpha-glucanase Proteins 0.000 description 1
- 238000002474 experimental method Methods 0.000 description 1
- 150000004665 fatty acids Chemical class 0.000 description 1
- 229930003935 flavonoid Natural products 0.000 description 1
- 150000002215 flavonoids Chemical class 0.000 description 1
- 235000017173 flavonoids Nutrition 0.000 description 1
- 150000002222 fluorine compounds Chemical class 0.000 description 1
- 235000013305 food Nutrition 0.000 description 1
- 235000003599 food sweetener Nutrition 0.000 description 1
- 238000005194 fractionation Methods 0.000 description 1
- 239000000417 fungicide Substances 0.000 description 1
- 229930195712 glutamate Natural products 0.000 description 1
- 150000004676 glycans Chemical class 0.000 description 1
- 229930182470 glycoside Natural products 0.000 description 1
- LPLVUJXQOOQHMX-UHFFFAOYSA-N glycyrrhetinic acid glycoside Natural products C1CC(C2C(C3(CCC4(C)CCC(C)(CC4C3=CC2=O)C(O)=O)C)(C)CC2)(C)C2C(C)(C)C1OC1OC(C(O)=O)C(O)C(O)C1OC1OC(C(O)=O)C(O)C(O)C1O LPLVUJXQOOQHMX-UHFFFAOYSA-N 0.000 description 1
- UYRUBYNTXSDKQT-UHFFFAOYSA-N glycyrrhizic acid Natural products CC1(C)C(CCC2(C)C1CCC3(C)C2C(=O)C=C4C5CC(C)(CCC5(C)CCC34C)C(=O)O)OC6OC(C(O)C(O)C6OC7OC(O)C(O)C(O)C7C(=O)O)C(=O)O UYRUBYNTXSDKQT-UHFFFAOYSA-N 0.000 description 1
- 229960004949 glycyrrhizic acid Drugs 0.000 description 1
- 235000019410 glycyrrhizin Nutrition 0.000 description 1
- LPLVUJXQOOQHMX-QWBHMCJMSA-N glycyrrhizinic acid Chemical compound O([C@@H]1[C@@H](O)[C@H](O)[C@H](O[C@@H]1O[C@@H]1C([C@H]2[C@]([C@@H]3[C@@]([C@@]4(CC[C@@]5(C)CC[C@@](C)(C[C@H]5C4=CC3=O)C(O)=O)C)(C)CC2)(C)CC1)(C)C)C(O)=O)[C@@H]1O[C@H](C(O)=O)[C@@H](O)[C@H](O)[C@H]1O LPLVUJXQOOQHMX-QWBHMCJMSA-N 0.000 description 1
- 239000008187 granular material Substances 0.000 description 1
- 229920003063 hydroxymethyl cellulose Polymers 0.000 description 1
- 229940031574 hydroxymethyl cellulose Drugs 0.000 description 1
- 239000003978 infusion fluid Substances 0.000 description 1
- 239000003456 ion exchange resin Substances 0.000 description 1
- 229920003303 ion-exchange polymer Polymers 0.000 description 1
- NFIDBGJMFKNGGQ-UHFFFAOYSA-N isopropylmethylphenol Natural products CC(C)CC1=CC=CC=C1O NFIDBGJMFKNGGQ-UHFFFAOYSA-N 0.000 description 1
- 235000010494 karaya gum Nutrition 0.000 description 1
- VQHSOMBJVWLPSR-JVCRWLNRSA-N lactitol Chemical compound OC[C@H](O)[C@@H](O)[C@@H]([C@H](O)CO)O[C@@H]1O[C@H](CO)[C@H](O)[C@H](O)[C@H]1O VQHSOMBJVWLPSR-JVCRWLNRSA-N 0.000 description 1
- 229940094522 laponite Drugs 0.000 description 1
- 239000010501 lemon oil Substances 0.000 description 1
- XCOBTUNSZUJCDH-UHFFFAOYSA-B lithium magnesium sodium silicate Chemical compound [Li+].[Li+].[OH-].[OH-].[OH-].[OH-].[OH-].[OH-].[OH-].[OH-].[OH-].[OH-].[OH-].[OH-].[Na+].[Na+].[Mg+2].[Mg+2].[Mg+2].[Mg+2].[Mg+2].[Mg+2].[Mg+2].[Mg+2].[Mg+2].[Mg+2].[Mg+2].[Mg+2].[Mg+2].[Mg+2].[Mg+2].[Mg+2].O1[Si](O2)([O-])O[Si]3([O-])O[Si]1([O-])O[Si]2([O-])O3.O1[Si](O2)([O-])O[Si]3([O-])O[Si]1([O-])O[Si]2([O-])O3.O1[Si](O2)([O-])O[Si]3([O-])O[Si]1([O-])O[Si]2([O-])O3.O1[Si](O2)([O-])O[Si]3([O-])O[Si]1([O-])O[Si]2([O-])O3.O1[Si](O2)([O-])O[Si]3([O-])O[Si]1([O-])O[Si]2([O-])O3.O1[Si](O2)([O-])O[Si]3([O-])O[Si]1([O-])O[Si]2([O-])O3 XCOBTUNSZUJCDH-UHFFFAOYSA-B 0.000 description 1
- 230000001050 lubricating effect Effects 0.000 description 1
- 239000004337 magnesium citrate Substances 0.000 description 1
- 229960005336 magnesium citrate Drugs 0.000 description 1
- 235000002538 magnesium citrate Nutrition 0.000 description 1
- VQHSOMBJVWLPSR-WUJBLJFYSA-N maltitol Chemical compound OC[C@H](O)[C@@H](O)[C@@H]([C@H](O)CO)O[C@H]1O[C@H](CO)[C@@H](O)[C@H](O)[C@H]1O VQHSOMBJVWLPSR-WUJBLJFYSA-N 0.000 description 1
- 235000010746 mayonnaise Nutrition 0.000 description 1
- 239000008268 mayonnaise Substances 0.000 description 1
- 239000002609 medium Substances 0.000 description 1
- 239000001525 mentha piperita l. herb oil Substances 0.000 description 1
- 239000001683 mentha spicata herb oil Substances 0.000 description 1
- 229920000609 methyl cellulose Polymers 0.000 description 1
- 150000004702 methyl esters Chemical class 0.000 description 1
- 229960001047 methyl salicylate Drugs 0.000 description 1
- 239000001923 methylcellulose Substances 0.000 description 1
- 229960002900 methylcellulose Drugs 0.000 description 1
- 235000010981 methylcellulose Nutrition 0.000 description 1
- 238000002156 mixing Methods 0.000 description 1
- 125000004108 n-butyl group Chemical group [H]C([H])([H])C([H])([H])C([H])([H])C([H])([H])* 0.000 description 1
- 229930014626 natural product Natural products 0.000 description 1
- 239000003921 oil Substances 0.000 description 1
- 235000019198 oils Nutrition 0.000 description 1
- 239000010502 orange oil Substances 0.000 description 1
- TWNQGVIAIRXVLR-UHFFFAOYSA-N oxo(oxoalumanyloxy)alumane Chemical compound O=[Al]O[Al]=O TWNQGVIAIRXVLR-UHFFFAOYSA-N 0.000 description 1
- RUVINXPYWBROJD-UHFFFAOYSA-N para-methoxyphenyl Natural products COC1=CC=C(C=CC)C=C1 RUVINXPYWBROJD-UHFFFAOYSA-N 0.000 description 1
- 235000019477 peppermint oil Nutrition 0.000 description 1
- 239000000419 plant extract Substances 0.000 description 1
- 229920001223 polyethylene glycol Polymers 0.000 description 1
- 229940068918 polyethylene glycol 400 Drugs 0.000 description 1
- 229920002503 polyoxyethylene-polyoxypropylene Polymers 0.000 description 1
- 229920001451 polypropylene glycol Polymers 0.000 description 1
- 229920001282 polysaccharide Polymers 0.000 description 1
- 239000005017 polysaccharide Substances 0.000 description 1
- 229920002451 polyvinyl alcohol Polymers 0.000 description 1
- 235000019422 polyvinyl alcohol Nutrition 0.000 description 1
- 239000001267 polyvinylpyrrolidone Substances 0.000 description 1
- 235000013855 polyvinylpyrrolidone Nutrition 0.000 description 1
- 229920000036 polyvinylpyrrolidone Polymers 0.000 description 1
- OQZCJRJRGMMSGK-UHFFFAOYSA-M potassium metaphosphate Chemical compound [K+].[O-]P(=O)=O OQZCJRJRGMMSGK-UHFFFAOYSA-M 0.000 description 1
- 229940099402 potassium metaphosphate Drugs 0.000 description 1
- 235000010333 potassium nitrate Nutrition 0.000 description 1
- 239000004323 potassium nitrate Substances 0.000 description 1
- 239000003755 preservative agent Substances 0.000 description 1
- 230000002265 prevention Effects 0.000 description 1
- 235000010409 propane-1,2-diol alginate Nutrition 0.000 description 1
- 239000000770 propane-1,2-diol alginate Substances 0.000 description 1
- 125000001436 propyl group Chemical group [H]C([*])([H])C([H])([H])C([H])([H])[H] 0.000 description 1
- 150000003242 quaternary ammonium salts Chemical class 0.000 description 1
- 239000001397 quillaja saponaria molina bark Substances 0.000 description 1
- 238000011160 research Methods 0.000 description 1
- 235000021283 resveratrol Nutrition 0.000 description 1
- 229940016667 resveratrol Drugs 0.000 description 1
- CVHZOJJKTDOEJC-UHFFFAOYSA-N saccharin Chemical compound C1=CC=C2C(=O)NS(=O)(=O)C2=C1 CVHZOJJKTDOEJC-UHFFFAOYSA-N 0.000 description 1
- 229940085605 saccharin sodium Drugs 0.000 description 1
- 239000010670 sage oil Substances 0.000 description 1
- 229930182490 saponin Natural products 0.000 description 1
- 150000007949 saponins Chemical class 0.000 description 1
- 108700004121 sarkosyl Proteins 0.000 description 1
- 239000010672 sassafras oil Substances 0.000 description 1
- 235000012239 silicon dioxide Nutrition 0.000 description 1
- 229940047670 sodium acrylate Drugs 0.000 description 1
- 235000010413 sodium alginate Nutrition 0.000 description 1
- 239000000661 sodium alginate Substances 0.000 description 1
- 229940005550 sodium alginate Drugs 0.000 description 1
- WXMKPNITSTVMEF-UHFFFAOYSA-M sodium benzoate Chemical compound [Na+].[O-]C(=O)C1=CC=CC=C1 WXMKPNITSTVMEF-UHFFFAOYSA-M 0.000 description 1
- 235000010234 sodium benzoate Nutrition 0.000 description 1
- 239000004299 sodium benzoate Substances 0.000 description 1
- 229910000029 sodium carbonate Inorganic materials 0.000 description 1
- 239000011780 sodium chloride Substances 0.000 description 1
- 239000001509 sodium citrate Substances 0.000 description 1
- NLJMYIDDQXHKNR-UHFFFAOYSA-K sodium citrate Chemical compound O.O.[Na+].[Na+].[Na+].[O-]C(=O)CC(O)(CC([O-])=O)C([O-])=O NLJMYIDDQXHKNR-UHFFFAOYSA-K 0.000 description 1
- 229940079841 sodium copper chlorophyllin Drugs 0.000 description 1
- 235000013758 sodium copper chlorophyllin Nutrition 0.000 description 1
- 229960001462 sodium cyclamate Drugs 0.000 description 1
- 229940074545 sodium dihydrogen phosphate dihydrate Drugs 0.000 description 1
- 229940080264 sodium dodecylbenzenesulfonate Drugs 0.000 description 1
- 239000011775 sodium fluoride Substances 0.000 description 1
- 235000013024 sodium fluoride Nutrition 0.000 description 1
- 229940075560 sodium lauryl sulfoacetate Drugs 0.000 description 1
- AQMNWCRSESPIJM-UHFFFAOYSA-M sodium metaphosphate Chemical compound [Na+].[O-]P(=O)=O AQMNWCRSESPIJM-UHFFFAOYSA-M 0.000 description 1
- UAJTZZNRJCKXJN-UHFFFAOYSA-M sodium;2-dodecoxy-2-oxoethanesulfonate Chemical compound [Na+].CCCCCCCCCCCCOC(=O)CS([O-])(=O)=O UAJTZZNRJCKXJN-UHFFFAOYSA-M 0.000 description 1
- 238000000638 solvent extraction Methods 0.000 description 1
- 238000000527 sonication Methods 0.000 description 1
- 235000010199 sorbic acid Nutrition 0.000 description 1
- 239000004334 sorbic acid Substances 0.000 description 1
- 229940075582 sorbic acid Drugs 0.000 description 1
- 239000000600 sorbitol Substances 0.000 description 1
- 235000019721 spearmint oil Nutrition 0.000 description 1
- ANOBYBYXJXCGBS-UHFFFAOYSA-L stannous fluoride Chemical compound F[Sn]F ANOBYBYXJXCGBS-UHFFFAOYSA-L 0.000 description 1
- 229960002799 stannous fluoride Drugs 0.000 description 1
- 150000005856 steroid saponins Chemical class 0.000 description 1
- OHHNJQXIOPOJSC-UHFFFAOYSA-N stevioside Natural products CC1(CCCC2(C)C3(C)CCC4(CC3(CCC12C)CC4=C)OC5OC(CO)C(O)C(O)C5OC6OC(CO)C(O)C(O)C6O)C(=O)OC7OC(CO)C(O)C(O)C7O OHHNJQXIOPOJSC-UHFFFAOYSA-N 0.000 description 1
- 229940013618 stevioside Drugs 0.000 description 1
- 235000019202 steviosides Nutrition 0.000 description 1
- 238000003756 stirring Methods 0.000 description 1
- 239000000126 substance Substances 0.000 description 1
- 239000000758 substrate Substances 0.000 description 1
- 150000005846 sugar alcohols Polymers 0.000 description 1
- 150000008163 sugars Chemical class 0.000 description 1
- BDHFUVZGWQCTTF-UHFFFAOYSA-M sulfonate Chemical compound [O-]S(=O)=O BDHFUVZGWQCTTF-UHFFFAOYSA-M 0.000 description 1
- 239000004094 surface-active agent Substances 0.000 description 1
- 239000003765 sweetening agent Substances 0.000 description 1
- 238000003786 synthesis reaction Methods 0.000 description 1
- 235000020357 syrup Nutrition 0.000 description 1
- 239000006188 syrup Substances 0.000 description 1
- 239000000892 thaumatin Substances 0.000 description 1
- 235000010436 thaumatin Nutrition 0.000 description 1
- 230000008719 thickening Effects 0.000 description 1
- 239000002562 thickening agent Substances 0.000 description 1
- 239000010678 thyme oil Substances 0.000 description 1
- 229960000790 thymol Drugs 0.000 description 1
- 239000004408 titanium dioxide Substances 0.000 description 1
- 229960005196 titanium dioxide Drugs 0.000 description 1
- OGIDPMRJRNCKJF-UHFFFAOYSA-N titanium oxide Inorganic materials [Ti]=O OGIDPMRJRNCKJF-UHFFFAOYSA-N 0.000 description 1
- 229940042585 tocopherol acetate Drugs 0.000 description 1
- PLSARIKBYIPYPF-UHFFFAOYSA-H trimagnesium dicitrate Chemical compound [Mg+2].[Mg+2].[Mg+2].[O-]C(=O)CC(O)(CC([O-])=O)C([O-])=O.[O-]C(=O)CC(O)(CC([O-])=O)C([O-])=O PLSARIKBYIPYPF-UHFFFAOYSA-H 0.000 description 1
- VXYADVIJALMOEQ-UHFFFAOYSA-K tris(lactato)aluminium Chemical compound CC(O)C(=O)O[Al](OC(=O)C(C)O)OC(=O)C(C)O VXYADVIJALMOEQ-UHFFFAOYSA-K 0.000 description 1
- 229940088594 vitamin Drugs 0.000 description 1
- 239000011782 vitamin Substances 0.000 description 1
- 235000013343 vitamin Nutrition 0.000 description 1
- 229930003231 vitamin Natural products 0.000 description 1
- 239000009637 wintergreen oil Substances 0.000 description 1
- 239000004711 α-olefin Substances 0.000 description 1
Landscapes
- Cosmetics (AREA)
- Medicines Containing Plant Substances (AREA)
Abstract
Description
【0001】[0001]
【発明の属する技術分野】本発明は、う蝕原因菌による
歯垢の形成を阻害する作用を有する抗う蝕剤に関し、さ
らに該抗う蝕剤を含有する口腔用組成物に関する。BACKGROUND OF THE INVENTION 1. Field of the Invention The present invention relates to an anti-cariogenic agent having an action of inhibiting the formation of dental plaque by cariogenic bacteria, and further relates to an oral composition containing the anti-cariogenic agent.
【0002】[0002]
【従来の技術】う蝕(虫歯)の原因となる歯垢は、スト
レプトコッカス・ミュータンスを中心とする口腔内細菌
により形成される。ストレプトコッカス・ミュータンス
はデキストラン合成酵素であるグルコシルトランスフェ
ラーゼを菌体外に産生し、ショ糖を基質として粘着性多
糖である不溶性グルカンを合成する。この不溶性グルカ
ン中で口腔内細菌が繁殖して歯垢が形成される。また、
ストレプトコッカス・ミュータンス等の口腔内細菌は種
々の糖を利用して産生する酸が、エナメル質表面を脱灰
し、う蝕を進行させる。従ってストレプトコッカス・ミ
ュータンスによる歯垢を形成させないことが、虫歯予防
にとってはきわめて重要なポイントとなる。近年、様々
な抗う蝕剤が提案されているものの、う蝕の予防は充分
ではなく、実際に利用しうる効果的な抗う蝕剤は未だ見
出されていないのが現状である。BACKGROUND OF THE INVENTION Dental plaque causing dental caries (cavities) is formed by oral bacteria, mainly Streptococcus mutans. Streptococcus mutans produces glucosyltransferase, a dextran synthase, outside the cells, and synthesizes insoluble glucan, a sticky polysaccharide, using sucrose as a substrate. Oral bacteria proliferate in this insoluble glucan to form plaque. Also,
In oral bacteria such as Streptococcus mutans, acids produced using various sugars demineralize the enamel surface and promote caries. Therefore, preventing the formation of plaque due to Streptococcus mutans is a very important point for preventing dental caries. In recent years, various anti-caries agents have been proposed, but prevention of dental caries is not sufficient, and no effective anti-caries agents that can be actually used have been found yet.
【0003】歯垢を形成させない方法として、ストレプ
トコッカス・ミュータンスをの増殖を抑制するための殺
菌剤、グルコシルトランスフェラーゼによる不溶性グル
カン合成の阻害剤、形成された不溶性グルカンを分解す
る酵素等の様々な抗う蝕剤が研究されている。中でも、
天然物由来物質は、比較的安全性が高いため研究対象と
して注目されている。例えば、特解昭58−12121
8号公報には、抗う蝕剤が開示されており、具体例とし
てタイソウ、ウイキョウ、芍薬、黄連、オウゴン、セン
ブリ等が挙げられている。しかしながら、その効果は、
期待されているものとはほど遠く、実際に利用しうる効
果的な抗う蝕剤は未だ見出されていないのが現状であ
る。Various methods for preventing the formation of plaque include antibacterial agents for suppressing the growth of Streptococcus mutans, inhibitors of insoluble glucan synthesis by glucosyltransferase, and enzymes for decomposing the formed insoluble glucan. Caries agents are being studied. Among them,
Substances derived from natural products are attracting attention as research targets because of their relatively high safety. For example, Japanese Patent Publication No. 58-12121
No. 8 discloses an anti-carious agent, and specific examples include syrup, fennel, shakuyaku, oren, Japanese gourd, and assemblage. However, the effect is
Far from what is expected, there is currently no effective anti-caries agent that can be used.
【0004】[0004]
【発明が解決しようとする課題】本発明の目的は、スト
レプトコッカス・ミュータンスによる歯垢形成を阻害す
ることのできる優れた抗う蝕剤を提供し、さらに、歯垢
形成を予防することのできる口腔用組成物を提供するこ
とである。SUMMARY OF THE INVENTION An object of the present invention is to provide an excellent anti-carious agent capable of inhibiting plaque formation by Streptococcus mutans, and furthermore, an oral cavity capable of preventing plaque formation. To provide a composition for use.
【0005】[0005]
【課題を解決するための手段】本発明者は、上記の目的
を達成するために鋭意研究を重ね、種々の植物抽出液を
スクリーニングして、ストレプトコッカス・ミュータン
スによる歯垢形成を効果的に阻害する天然由来の抽出物
を探索した。その結果、ユッカの抽出物がこれにたいし
て強力な阻害作用を有してう蝕の予防に有用であること
を見出し、本発明を完成するに至った。従って本発明
は、ユッカ抽出物を含有することを特徴とする抗う蝕剤
である。本発明はさらに、上記抗う蝕剤を含有している
ことを特徴とする口腔用組成物である。Means for Solving the Problems The present inventors have conducted intensive studies in order to achieve the above object, and have screened various plant extracts to effectively inhibit plaque formation by Streptococcus mutans. To search for naturally occurring extracts. As a result, they found that the extract of Yucca had a strong inhibitory effect on it and was useful for preventing caries, and completed the present invention. Accordingly, the present invention is an anti-cariogenic agent characterized by containing a Yucca extract. The present invention further provides an oral composition comprising the above anti-carious agent.
【0006】[0006]
【発明の実施の形態】以下、本発明を詳細に説明する。
原料のユッカ(Yucca)としては、Yucca arizonica、Yu
cca brevifolia、Yucca schidigera、Yucca elata、Yuc
ca intermdia、Yucca recurvifolia Salisb、Yucca sma
lliana Fernald、Yucca aloifolia Linn、Yucca glorio
sa Linn、Yuccamohavensis、Yucca peninsularis、Yucc
a schottii、Yucca whipplei等があり、これらの一種を
用いてもよいし、二種以上を用いてもよい。ユッカは地
上茎、地上部(種子を含む)とも抽出原料として使用する
ことができる。原料は適宜適当な大きさに粉砕してか
ら、抽出溶媒として水、親水性有機溶媒又はこれらの混
合物で抽出処理する。水と親水性有機溶媒との混合物を
使用する場合、水の含有量は全体の70容量%程度まで
が適当である。抽出用の親水性有機溶媒としては、メタ
ノール、エタノールなどの低級アルコール、グリセリ
ン、1,3−ブチレングリコール、プロピレングリコール
などの多価アルコール、アセトン等が好ましい。抽出溶
媒の使用量は、重量で抽出原料の3〜10倍量程度が適
当である。BEST MODE FOR CARRYING OUT THE INVENTION Hereinafter, the present invention will be described in detail.
Yucca (Yucca) as raw material includes Yucca arizonica and Yu
cca brevifolia, Yucca schidigera, Yucca elata, Yuc
ca intermdia, Yucca recurvifolia Salisb, Yucca sma
lliana Fernald, Yucca aloifolia Linn, Yucca glorio
sa Linn, Yuccamohavensis, Yucca peninsularis, Yucc
a schottii, Yucca whipplei, and the like. One of these may be used, or two or more thereof may be used. Yucca can be used as an extraction raw material for both above-ground stems and above-ground parts (including seeds). The raw material is appropriately ground to an appropriate size, and then subjected to extraction treatment with water, a hydrophilic organic solvent, or a mixture thereof as an extraction solvent. When a mixture of water and a hydrophilic organic solvent is used, the content of water is suitably up to about 70% by volume of the whole. As the hydrophilic organic solvent for extraction, lower alcohols such as methanol and ethanol, polyhydric alcohols such as glycerin, 1,3-butylene glycol and propylene glycol, and acetone are preferable. The amount of the extraction solvent used is suitably about 3 to 10 times the weight of the extraction raw material.
【0007】抽出方法は、特に制限が無く、一般には常
温ないし沸点付近の温度に維持した溶媒中に原料を浸漬
しておけばよい。溶媒抽出によらず、ステロイドサポニ
ン含有エキスを得る方法として、新鮮な植物体を原料に
して搾汁する方法もある。また、所定の抽出溶媒にて抽
出して得た抽出液をそのまま用いる以外に、この抽出液
を濃縮してもよいし、乾燥させて固形物(粉末状または
顆粒状)にしてもよい。さらに、イオン交換樹脂を充填
したカラムにより、水、親水性有機溶媒あるいはこれら
の混液を用いて分画を行い、サポニン、フラボノイド、
レスベラトロールの一種または二種以上を主成分とする
抽出物を用いてもよい。本抽出物としては通常食品など
に使用されているものが使用でき、それらは市場で入手
することができる。例えば、ミツバ貿易(株)から入手
可能なユッカフォーメーション50、ユッカエキスパウ
ダー、ユッカサラサポニン50−M、ユッカサラサポニ
ン80−Mなどが挙げられる。本発明品においては、そ
のような市販品を使用することができる。[0007] The extraction method is not particularly limited, and generally the raw material may be immersed in a solvent maintained at a normal temperature or a temperature near the boiling point. As a method of obtaining a steroid saponin-containing extract without resorting to solvent extraction, there is a method of squeezing a fresh plant body as a raw material. In addition to using an extract obtained by extraction with a predetermined extraction solvent as it is, the extract may be concentrated or dried to a solid (powder or granule). Furthermore, by using a column filled with an ion exchange resin, fractionation is performed using water, a hydrophilic organic solvent or a mixture thereof, and saponin, flavonoid,
An extract containing one or more resveratrol as a main component may be used. As the extract, those commonly used in foods and the like can be used, and they can be obtained on the market. For example, Yucca Formation 50, Yucca Extract Powder, Yucca Sarasaponin 50-M, Yucca Sarasaponin 80-M available from Mitsuba Trading Co., Ltd. are exemplified. In the product of the present invention, such a commercially available product can be used.
【0008】本発明の抗う蝕剤は、上記のようにして得
たユッカ抽出物を有効成分とする。本発明の抗う蝕剤は
液状、固形状、半固形状のいずれでもよい。本発明の抗
う蝕剤の用途は医薬品、医薬部外品、口腔用組成物など
に広く用いることができる。本発明の口腔用組成物にお
ける上記抗う蝕剤の含有量は、口腔用組成物の全重量に
基づいて、該抗う蝕剤の有効成分であるユッカ抽出物と
して0.01〜20重量%が適当であり、好ましくは0.0
5〜10重量%である。口腔用組成物において、ユッカ
抽出物が0.01重量%よりも少ないと、抗う蝕剤として
の効果に乏しくなる場合があり、また、20重量%より
も多いと効果が頭打ちとなり経済的に不利になる場合が
ある。本発明の口腔用組成物は、練歯磨、潤製歯磨、液
体歯磨等の歯磨剤、洗口液、マウスウォッシュ、口中清
涼剤、うがい用錠剤、義歯用洗浄剤、チューインガム等
の形態とすることができる。これらは、上記抗う蝕剤を
含有してなるものであるが、その特徴に応じ他の成分を
本発明の効果を損ねない範囲で配合し、通常の方法で調
製することができる。The anti-caries agent of the present invention comprises the yucca extract obtained as described above as an active ingredient. The anti-caries agent of the present invention may be any of a liquid, a solid, and a semi-solid. The anti-caries agent of the present invention can be widely used for pharmaceuticals, quasi-drugs, oral compositions, and the like. The content of the anti-cariogenic agent in the oral composition of the present invention is preferably 0.01 to 20% by weight as Yucca extract, which is an active ingredient of the anti-carious agent, based on the total weight of the oral composition. And preferably 0.0
5 to 10% by weight. In the oral composition, if the Yucca extract is less than 0.01% by weight, the effect as an anti-cariogenic agent may be poor, and if it is more than 20% by weight, the effect may plateau and become economically disadvantageous. May be. The oral composition of the present invention is in the form of dentifrice such as toothpaste, lubricating toothpaste, liquid dentifrice, mouthwash, mouthwash, mouthwash, mouthwash tablet, denture cleaner, chewing gum and the like. Can be. These contain the above-mentioned anti-carious agent, but can be prepared by a usual method by blending other components according to the characteristics thereof within a range that does not impair the effects of the present invention.
【0009】具体的には、練歯磨などの歯磨剤には、研
磨剤として結晶質シリカ、非晶質シリカ、その他のシリ
カ系研磨剤、アルミノシリケート、酸化アルミニウム、
水酸化アルミニウム、不溶性メタリン酸ナトリウム、不
溶性メタリン酸カリウム、酸化チタン、第2リン酸カル
シウム・2水和物、重質炭酸カルシウム、軽質炭酸カル
シウム等(通常配合量3〜99重量%)、粘結剤として
カラゲナン、カルボキシメチルセルロース、メチルセル
ロース、ヒドロキシメチルセルロース、カルボキシメチ
ルヒドロキシメチルセルロースナトリウム等のセルロー
ス誘導体、アルギン酸ナトリウムなどのアルカリ金属ア
ルギネート、アルギン酸プロピレングリコールエステ
ル、キサンタンガム、トラガントガム、カラヤガム、ア
ラビアガム等のガム類、ポリビニルアルコール、ポリア
クリル酸ナトリウム、カルボキシビニルポリマー、ポリ
ビニルピロリドン等の合成粘結剤、ゲル化性シリカ、ゲ
ル化性アルミニウムシリカ、ビーガント、ラポナイト等
の無機粘結剤(通常配合量0.5〜10重量%)、粘稠剤
としてソルビット、グリセリン、エチレングリコール、
プロピレングリコール、1,3−ブチレングリコール、ポ
リエチレングリコール、ポリプロピレングリコール、キ
シリット、マルチット、ラクチット等(通常配合量1〜
50重量%)を配合することができる。More specifically, dentifrices such as toothpastes include crystalline silica, amorphous silica, other silica-based abrasives, aluminosilicate, aluminum oxide,
Aluminum hydroxide, insoluble sodium metaphosphate, insoluble potassium metaphosphate, titanium oxide, dibasic calcium phosphate dihydrate, heavy calcium carbonate, light calcium carbonate, etc. (usually 3 to 99% by weight), as a binder Carrageenan, carboxymethylcellulose, methylcellulose, hydroxymethylcellulose, cellulose derivatives such as sodium carboxymethylhydroxymethylcellulose, alkali metal alginate such as sodium alginate, propylene glycol alginate, xanthan gum, tragacanth gum, gum such as gum karaya, gum arabic, polyvinyl alcohol, poly Synthetic binders such as sodium acrylate, carboxyvinyl polymer, polyvinylpyrrolidone, gelling silica, gelling aluminum Rica, Biganto, inorganic binders such as Laponite (usually amount from 0.5 to 10% by weight), sorbitol as thickener, glycerin, ethylene glycol,
Propylene glycol, 1,3-butylene glycol, polyethylene glycol, polypropylene glycol, xylit, maltit, lactit, etc.
50% by weight).
【0010】また、界面活性剤としては、例えばラウリ
ル硫酸ナトリウム、α−オレフィンスルホン酸ナトリウ
ム、ドデシルベンゼンスルホン酸ナトリウム、ラウリル
スルホ酢酸ナトリウム、N−ラウロイルザルコシン酸ナ
トリウム、N−アシルグルタミン酸塩、ショ糖脂肪酸エ
ステル、ポリオキシエチレン硬化ヒマシ油、ポリオキシ
エチレンポリオキシプロピレンブロック共重合体、アル
キルグリコシド類、ソルビタン脂肪酸エステル、ポリオ
キシエチレンソルビタン脂肪酸エステル、アルキルジメ
チルアミンオキシド等が挙げられ、その配合量は通常0
〜5重量%である。Examples of the surfactant include sodium lauryl sulfate, sodium α-olefin sulfonate, sodium dodecylbenzene sulfonate, sodium lauryl sulfoacetate, sodium N-lauroyl sarcosinate, N-acyl glutamate, and sucrose. Fatty acid esters, polyoxyethylene hydrogenated castor oil, polyoxyethylene polyoxypropylene block copolymers, alkyl glycosides, sorbitan fatty acid esters, polyoxyethylene sorbitan fatty acid esters, alkyl dimethylamine oxide, etc. 0
~ 5% by weight.
【0011】更に任意成分として、例えばキシリトー
ル、サッカリンナトリウム、ステビオサイド、グリチル
リチン、ペリラルチン、タウマチン、アスパラチルフェ
ニルアラニンメチルエステル、p−メトキシシンアミッ
クアルデヒド、ショ糖、果糖、サイクラミン酸ナトリウ
ム等の甘味料、スペアミント油、ペパーミント油、ウイ
ンターグリーン油、サッサフラス油、チョウジ油、ユー
カリ油、セージ油、マヨナラ油、タイム油、レモン油、
オレンジ油、1−メントール、カルボン、アネトール、
オイゲノール、チモール、サリチル酸メチルなどの香
料、安息香酸、安息香酸ナトリウム、p−ヒドロキシプ
ロピルベンゾイックアシッド、p−ヒドロキシブチルベ
ンゾイックアシッド、低級脂肪酸モノグリセライドなど
の防腐剤、Further, as optional components, for example, sweeteners such as xylitol, sodium saccharin, stevioside, glycyrrhizin, perillartin, thaumatin, asparatylphenylalanine methyl ester, p-methoxycinamic acid, sucrose, fructose, sodium cyclamate, spearmint oil, Peppermint oil, wintergreen oil, sassafras oil, clove oil, eucalyptus oil, sage oil, mayonnaise oil, thyme oil, lemon oil,
Orange oil, 1-menthol, carvone, anethole,
Eugenol, thymol, flavors such as methyl salicylate, preservatives such as benzoic acid, sodium benzoate, p-hydroxypropyl benzoic acid, p-hydroxybutyl benzoic acid, lower fatty acid monoglyceride,
【0012】第4級アンモニウム塩、トリクロサン、塩
酸アルキルジアミノエチルグリシン等の殺菌剤、イプシ
ロンアミノカプロン酸、デキストラナーゼ、アミラー
ゼ、プロテアーゼ、ムタナーゼ、溶菌酵素、リゾチーム
等の酵素、モノフルオロリン酸ナトリウム、モノフルオ
ロリン酸カリウム、フッ化ナトリウム、フッ化アンモニ
ウム、フッ化第一スズなどのフッ化物、クロルヘキシジ
ン塩類、ジヒドロコレステロール、グリチルレチン塩
類、グリチルレチン酸、クロロフィル、カロペプタイ
ド、ビタミン類、アズレン、塩化リゾチーム、歯石防止
剤、歯垢防止剤、硝酸カリウム、乳酸アルミニウムなど
を添加することができる。なお、これらの任意成分の添
加量は、本発明を防げない範囲で通常量とすることがで
きる。Fungicides such as quaternary ammonium salts, triclosan, and alkyldiaminoethylglycine hydrochloride; epsilon aminocaproic acid; enzymes such as dextranase, amylase, protease, mutanase, lytic enzyme, and lysozyme; sodium monofluorophosphate; Fluorides such as potassium fluorophosphate, sodium fluoride, ammonium fluoride, stannous fluoride, chlorhexidine salts, dihydrocholesterol, glycyrrhetin salts, glycyrrhetinic acid, chlorophyll, caropeptides, vitamins, azulene, lysozyme chloride, anticalculus agents , A plaque inhibitor, potassium nitrate, aluminum lactate and the like. In addition, the addition amount of these optional components can be a normal amount within a range that does not prevent the present invention.
【0013】[0013]
【実施例】以下に試験例および実施例により、本発明を
さらに詳細に説明するが、これらの実施例は本発明の範
囲を制限するものではない。The present invention will be described in more detail with reference to the following Test Examples and Examples, which do not limit the scope of the present invention.
【試験例】<歯垢付着抑制実験>ストレプトコッカス・
ミュータンスの試験管壁への付着抑制効果を下記の方法
で評価した。結果を表1に示す。ストレプトコッカス・
ミュータンス菌6715株(gタイプ)をブレインハー
トインフュージョン液体培地(BHI培地)で37℃,
24時間培養して得られた菌液0.1mlと5%ショ糖添
加BHI培地4.5mlおよびユッカ抽出物あるいは滅菌
精製水0.5mlを試験管内で混合し検液とし、30°の
角度に傾け37℃、18時間培養した。なお、上記検液
において、ユッカ抽出物濃度を0.2〜5.0%で変動させ
た。培養後,BHI培地および浮遊物を破棄した。次に
5mlの精製水を静かに加え、ボルテックスミキサーで1
分間攪拌して付着性の弱い歯垢を洗浄し、試験管壁に残
った不溶物を付着菌体とした。5mlの精製水を試験管に
加え超音波処理により付着菌体を懸濁させ、濁度を吸光
度550nmで測定した。ユッカ抽出物の代わりに滅菌精
製水を用いた実験をコントロールとして、歯垢付着阻害
活性を評価した。付着阻害率は次式により算出した。 付着阻害率(%)=(1−試料の濁度/コントロールの
濁度)×100[Test Example] <Determination of plaque adhesion> Streptococcus
The effect of suppressing the adhesion of the mutans to the test tube wall was evaluated by the following method. Table 1 shows the results. Streptococcus
Mutant strain 6715 (g type) was cultured at 37 ° C. in a brain heart infusion liquid medium (BHI medium).
0.1 ml of the bacterial solution obtained by culturing for 24 hours, 4.5 ml of 5% sucrose-added BHI medium and 0.5 ml of Yucca extract or sterilized purified water were mixed in a test tube to prepare a test solution. The culture was performed at 37 ° C. for 18 hours. In the above test solution, the concentration of the Yucca extract was varied between 0.2 and 5.0%. After the culture, the BHI medium and the suspended matter were discarded. Next, gently add 5 ml of purified water, and mix with a vortex mixer.
The plaque with weak adhesion was washed by stirring for minutes, and the insoluble matter remaining on the test tube wall was regarded as adherent cells. 5 ml of purified water was added to the test tube, the adherent cells were suspended by sonication, and the turbidity was measured at an absorbance of 550 nm. The plaque adhesion inhibitory activity was evaluated using an experiment using sterile purified water instead of the Yucca extract as a control. The adhesion inhibition rate was calculated by the following equation. Adhesion inhibition rate (%) = (1−turbidity of sample / turbidity of control) × 100
【0014】[0014]
【表1】歯垢付着阻害率(%) 表1から、ユッカ抽出物は歯垢付着阻害作用を持ち、有
効な抗う蝕剤であることが認められた。[Table 1] Plaque adhesion inhibition rate (%) From Table 1, it was confirmed that the Yucca extract had an inhibitory action on plaque adhesion and was an effective anti-carious agent.
【0015】以下に、ユッカ抽出物を配合した口腔内組
成物の実施例を示す.The following is an example of an intraoral composition containing a yucca extract.
【実施例1】練歯磨剤の調製 以下の処方(単位:重量%)にて、練歯磨剤を常法に従
って調製した。 リン酸水素カルシウム無水和物 20.0 リン酸水素カルシウム2水和物 20.0 無水ケイ酸 5.0 カラーギナン 0.7 カルボキシメチルセルロースナトリウム 0.3 グリセリン 20.0 70%ソルビット液 10.0 トリクロサン 0.1 サッカリンナトリウム 0.1 ラウリル硫酸ナトリウム 1.5 ユッカ抽出物(ユッカサラサポニン80-M) 0.1 香料 1.0 精製水 残 合計 100.0%Example 1 Preparation of toothpaste A toothpaste was prepared according to a conventional method with the following formulation (unit: wt%). Calcium hydrogen phosphate anhydrate 20.0 Calcium hydrogen phosphate dihydrate 20.0 Silicic anhydride 5.0 Carrageenan 0.7 Sodium carboxymethyl cellulose 0.3 Glycerin 20.0 70% sorbite solution 10.0 Triclosan 0 .1 Saccharin sodium 0.1 Sodium lauryl sulfate 1.5 Yucca extract (Yucca saraponin 80-M) 0.1 Perfume 1.0 Purified water balance Total 100.0%
【0016】[0016]
【実施例2】練歯磨剤の調製 以下の処方(単位:重量%)にて、練歯磨剤を常法に従
って調製した。 無水ケイ酸 20.0 二酸化チタン 0.5 カラーギナン 1.0 プロピレングリコール 3.0 70%ソルビット液 20.0 グリセリン 20.0 モノフルオロリン酸ナトリウム 0.05 塩化セチルピリジニウム 0.1 ラウリル硫酸ナトリウム 1.7 ラウロイルサルコシンナトリウム 0.3 銅クロロフィリンナトリウム 0.05 ユッカ抽出物(ユッカサラサポニン80-M) 0.1 香料 1.0 精製水 残 合計 100.0%Example 2 Preparation of toothpaste A toothpaste was prepared according to a conventional method with the following formulation (unit: wt%). Silicic anhydride 20.0 Titanium dioxide 0.5 Carrageenan 1.0 Propylene glycol 3.0 70% sorbite solution 20.0 Glycerin 20.0 Sodium monofluorophosphate 0.05 Cetylpyridinium chloride 0.1 Sodium lauryl sulfate 1. 7 Sodium lauroyl sarcosine 0.3 Sodium copper chlorophyllin 0.05 Yucca extract (Yuca sarasaponin 80-M) 0.1 Perfume 1.0 Purified water balance Total 100.0%
【0017】[0017]
【実施例3】練歯磨剤の調製 以下の処方(単位:重量%)にて、練歯磨剤を常法に従
って調製した。 水酸化アルミニウム 30.0 無水ケイ酸 5.0 塩化ナトリウム 10.0 カルボキシメチルセルロースナトリウム(DS:0.7) 0.1 カルボキシメチルセルロースナトリウム(DS:1.0) 0.9 グリセリン 20.0 ラウリル硫酸ナトリウム 1.8 イソプロピルメチルフェノール 0.02 酢酸 dl−αトコフェロール 0.1 ポリオキシエチレン硬化ヒマシ油 3.0 パラオキシ安息香酸エチル 0.1 ユッカ抽出液(ユッカサラサポニン80-M) 0.1 香料 1.0 精製水 残 合計 100.0%Example 3 Preparation of toothpaste A toothpaste was prepared according to a conventional method with the following formulation (unit:% by weight). Aluminum hydroxide 30.0 Silicic anhydride 5.0 Sodium chloride 10.0 Sodium carboxymethylcellulose (DS: 0.7) 0.1 Sodium carboxymethylcellulose (DS: 1.0) 0.9 Glycerin 20.0 Sodium lauryl sulfate 1.8 Isopropyl Methylphenol 0.02 dl-α-tocopherol acetate 0.1 Polyoxyethylene hydrogenated castor oil 3.0 Ethyl parahydroxybenzoate 0.1 Yucca extract (Yucca salaponin 80-M) 0.1 Perfume 1.0 Purified water residue 100.0% in total
【0018】[0018]
【実施例4】練歯磨剤の調製 以下の処方(単位:重量%)にて、練歯磨剤を常法に従
って調製した。 ピロリン酸カルシウム 32.0 無水ケイ酸 6.0 カルボキシメチルセルロースナトリウム(DS:0.7) 0.2 カルボキシメチルセルロースナトリウム(DS:1.0) 0.8 グリセリン 25.0 グリチルレチン酸 0.2 塩化セチルピリジニウム 0.05 イプシロンアミノカプロン酸 0.1 ユッカ抽出物(ユッカサラサポニン80-M) 0.1 香料 0.1 精製水 残 合計 100.0%Example 4 Preparation of Toothpaste A toothpaste was prepared according to a conventional method according to the following formulation (unit:% by weight). Calcium pyrophosphate 32.0 Silicic anhydride 6.0 Sodium carboxymethylcellulose (DS: 0.7) 0.2 Sodium carboxymethylcellulose (DS: 1.0) 0.8 Glycerin 25.0 Glycyrrhetinic acid 0.2 Cetylpyridinium chloride 0.05 Epsilon aminocapron Acid 0.1 Yucca extract (Yucca salaponin 80-M) 0.1 Perfume 0.1 Purified water Residue Total 100.0%
【0019】[0019]
【実施例5】液状歯磨剤の調製 以下の処方(単位:重量%)にて、液状歯磨剤を常法に
従って調製した。 無水ケイ酸 10.0 キサンタンガム 1.0 グリセリン 10.0 70%ソルビット液 30.0 キシリトール 1.0 パラオキシ安息香酸エチル 0.1 パラオキシ安息香酸ブチル 0.05 リン酸二水素ナトリウム2水和物 0.3 水酸化ナトリウム 0.05 ユッカ抽出物(ユッカサラサポニン80-M) 0.1 香料 0.5 精製水 残 合計 100.0%Example 5 Preparation of Liquid Dentifrice A liquid dentifrice was prepared according to a conventional method with the following formulation (unit:% by weight). Silicic anhydride 10.0 Xanthan gum 1.0 Glycerin 10.0 70% sorbite solution 30.0 Xylitol 1.0 Ethyl parahydroxybenzoate 0.1 Butyl paraoxybenzoate 0.05 Sodium dihydrogen phosphate dihydrate 0. 3 Sodium hydroxide 0.05 Yucca extract (Yucca salsaponin 80-M) 0.1 Perfume 0.5 Purified water balance Total 100.0%
【0020】[0020]
【実施例6】洗口剤の調製 以下の処方(単位:重量%)にて、洗口液を常法に従っ
て調製した。 変性アルコール56号 5.0 ポリオキシエチレン硬化ヒマシ油 0.5 グリセリン 5.0 キシリトール 25.0 塩化セチルピリジニウム 0.05 グリチルリチン酸ジカリウム 0.05 パラオキシ安息香酸エチル 0.05 パラオキシ安息香酸プロピル 0.05 クエン酸 0.03 クエン酸ナトリウム 0.12 黄色4号 0.0002 緑色3号 0.0002 ユッカ抽出物(ユッカサラサポニン80-M) 0.1 精製水 残 合計 100.0%Example 6 Preparation of Mouthwash Mouthwash was prepared according to a conventional method with the following formulation (unit: wt%). Denatured Alcohol No. 56 5.0 Polyoxyethylene hydrogenated castor oil 0.5 Glycerin 5.0 Xylitol 25.0 Cetylpyridinium chloride 0.05 Dipotassium glycyrrhizinate 0.05 Ethyl paraoxybenzoate 0.05 Propyl paraoxybenzoate 0.05 Citric acid 0.03 Sodium citrate 0.12 Yellow No. 4 0.0002 Green No. 3 0.0002 Yucca extract (Yucca salasaponin 80-M) 0.1 Purified water Remaining 100.0%
【0021】[0021]
【実施例7】チューインガムの調製 以下の処方(単位:重量%)にて、チューインガムを常
法に従って調製した。 ガムベース 40.0 炭酸カルシウム 2.0 水アメ 15.0 砂糖 30.0 クエン酸マグネシウム 2.55 ソルビン酸 0.2 ユッカ抽出液(ユッカサラサポニン80-M) 0.1 精製水 残 100.0%Example 7 Preparation of chewing gum Chewing gum was prepared according to a conventional method according to the following formulation (unit:% by weight). Gum base 40.0 Calcium carbonate 2.0 Water candy 15.0 Sugar 30.0 Magnesium citrate 2.55 Sorbic acid 0.2 Yucca extract (Yucca salasaponin 80-M) 0.1 Purified water balance 100.0%
【0022】[0022]
【実施例8】義歯洗浄剤ペーストの調製 以下の処方(単位:重量%)にて、義歯洗浄剤ペースト
を常法に従って調製した。 無水ケイ酸 3.0 増粘性シリカ 10.0 ポリエチレングリコール400 5.0 グリセリン 35.0 60%ソルビット液 30.0 ラウリル硫酸ナトリウム 2.0 カルボキシメチルセルロースナトリウム 1.5 香料 1.0 ユッカ抽出液 (ユッカサラサポニン80-M) 0.1 炭酸ナトリウム 適量 精製水 残 合計 100.0%Example 8 Preparation of Denture Cleanser Paste A denture cleanser paste was prepared according to a conventional method according to the following formulation (unit:% by weight). Silicic anhydride 3.0 Thickening silica 10.0 Polyethylene glycol 400 5.0 Glycerin 35.0 60% sorbite solution 30.0 Sodium lauryl sulfate 2.0 Sodium carboxymethyl cellulose 1.5 Flavor 1.0 Yucca extract (Yucca) Sarasaponin 80-M) 0.1 Appropriate amount of sodium carbonate Purified water balance Total 100.0%
【発明の効果】本発明のユッカ抽出物を有効成分とする
抗う蝕剤は,ストレプトコッカス・ミュータンスによる
歯垢形成を顕著に阻害する。従って、これを口腔用組成
物の成分とすることにより、う蝕の予防効果に優れた口
腔用組成物を提供することができる。The anticariogenic agent containing the yucca extract of the present invention as an active ingredient remarkably inhibits plaque formation by Streptococcus mutans. Therefore, by using this as a component of the oral composition, it is possible to provide an oral composition having an excellent effect of preventing dental caries.
───────────────────────────────────────────────────── フロントページの続き Fターム(参考) 4C083 AA111 AA112 AB032 AB172 AB222 AB242 AB292 AB322 AB332 AB472 AC102 AC122 AC132 AC252 AC302 AC432 AC472 AC482 AC622 AC662 AC692 AC782 AC792 AC812 AC852 AC862 AC932 AD042 AD222 AD242 AD272 AD352 AD532 AD662 CC41 DD22 DD23 EE32 ──────────────────────────────────────────────────続 き Continued on the front page F term (reference) 4C083 AA111 AA112 AB032 AB172 AB222 AB242 AB292 AB322 AB332 AB472 AC102 AC122 AC132 AC252 AC302 AC432 AC472 AC482 AC622 AC662 AC692 AC782 AC792 AC812 AC852 AC862 AC932 AD042 AD222 AD242 AD272 AD352 AD532 AD662 CC41 DD22 EE32
Claims (3)
る抗う蝕剤。1. An anti-cariogenic agent comprising a yucca extract.
を特徴とする口腔用組成物。2. An oral composition comprising the anti-caries agent according to claim 1.
することを特徴とする口腔用組成物。3. An oral composition comprising 0.01 to 20% by weight of a yucca extract.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP25994699A JP4672096B2 (en) | 1999-09-14 | 1999-09-14 | Anti-caries agent and oral composition containing the same |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP25994699A JP4672096B2 (en) | 1999-09-14 | 1999-09-14 | Anti-caries agent and oral composition containing the same |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2001081019A true JP2001081019A (en) | 2001-03-27 |
| JP4672096B2 JP4672096B2 (en) | 2011-04-20 |
Family
ID=17341125
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP25994699A Expired - Fee Related JP4672096B2 (en) | 1999-09-14 | 1999-09-14 | Anti-caries agent and oral composition containing the same |
Country Status (1)
| Country | Link |
|---|---|
| JP (1) | JP4672096B2 (en) |
Citations (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US259389A (en) * | 1882-06-13 | Ed ward hekdebson | ||
| JPS53133645A (en) * | 1977-04-22 | 1978-11-21 | Michel George H | Breath deodorizing composition |
| JPS63119416A (en) * | 1986-11-07 | 1988-05-24 | Yasutake Hichi | Anticarious substance |
| JPH03120209A (en) * | 1989-10-04 | 1991-05-22 | Kikkoman Corp | Cariostatic agent |
| JPH04187658A (en) * | 1990-11-21 | 1992-07-06 | Hokkaido Togyo Kk | Water-soluble pentacyclic triterpene clathrate compound, method for producing the same, and food, beverage, and oral compositions using the same |
| CN1111123A (en) * | 1994-05-05 | 1995-11-08 | 成都市新津国立生物工程研究所 | multifunctional liquid toothpaste |
-
1999
- 1999-09-14 JP JP25994699A patent/JP4672096B2/en not_active Expired - Fee Related
Patent Citations (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US259389A (en) * | 1882-06-13 | Ed ward hekdebson | ||
| JPS53133645A (en) * | 1977-04-22 | 1978-11-21 | Michel George H | Breath deodorizing composition |
| JPS63119416A (en) * | 1986-11-07 | 1988-05-24 | Yasutake Hichi | Anticarious substance |
| JPH03120209A (en) * | 1989-10-04 | 1991-05-22 | Kikkoman Corp | Cariostatic agent |
| JPH04187658A (en) * | 1990-11-21 | 1992-07-06 | Hokkaido Togyo Kk | Water-soluble pentacyclic triterpene clathrate compound, method for producing the same, and food, beverage, and oral compositions using the same |
| CN1111123A (en) * | 1994-05-05 | 1995-11-08 | 成都市新津国立生物工程研究所 | multifunctional liquid toothpaste |
Also Published As
| Publication number | Publication date |
|---|---|
| JP4672096B2 (en) | 2011-04-20 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| US6500409B1 (en) | Synergistic antiplaque/antigingivitis oral composition | |
| AU703912B2 (en) | Antimicrobial oral composition | |
| EP2594255B1 (en) | Dentifrice composition | |
| JP2002020253A (en) | Composition for oral use | |
| DE60004998T2 (en) | SYNERGISTIC ANTIBACTERIAL COMBINATION | |
| EP0348560A1 (en) | Oral composition | |
| JPH08175947A (en) | Oral composition | |
| JP2002234825A (en) | Composition for oral cavity application | |
| JPH08175945A (en) | Oral composition | |
| JPH08175946A (en) | Oral composition | |
| JP5054914B2 (en) | Oral composition | |
| JP2001089385A (en) | Anti-dental caries agent | |
| JP2005239655A (en) | Composition for oral cavity | |
| JP3336688B2 (en) | Oral composition | |
| JP3189549B2 (en) | Oral composition | |
| JPH08231361A (en) | Oral composition | |
| JP2006022054A (en) | Composition for oral cavity | |
| JP4672096B2 (en) | Anti-caries agent and oral composition containing the same | |
| KR101773227B1 (en) | Dentrifice composition | |
| JPH0495020A (en) | Enzyme inhibitor | |
| JP2738092B2 (en) | Oral composition | |
| JP2001089345A (en) | Anti-dental caries agent | |
| JP2001097835A (en) | Dental caries inhibitor | |
| JP2001089344A (en) | Anti-dental caries agent | |
| JP7779115B2 (en) | Oral composition |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| A621 | Written request for application examination |
Free format text: JAPANESE INTERMEDIATE CODE: A621 Effective date: 20060913 |
|
| A977 | Report on retrieval |
Free format text: JAPANESE INTERMEDIATE CODE: A971007 Effective date: 20080331 |
|
| A131 | Notification of reasons for refusal |
Free format text: JAPANESE INTERMEDIATE CODE: A131 Effective date: 20090406 |
|
| A521 | Written amendment |
Free format text: JAPANESE INTERMEDIATE CODE: A523 Effective date: 20090605 |
|
| A521 | Written amendment |
Free format text: JAPANESE INTERMEDIATE CODE: A821 Effective date: 20090605 |
|
| A02 | Decision of refusal |
Free format text: JAPANESE INTERMEDIATE CODE: A02 Effective date: 20100513 |
|
| A521 | Written amendment |
Free format text: JAPANESE INTERMEDIATE CODE: A523 Effective date: 20100812 |
|
| A911 | Transfer of reconsideration by examiner before appeal (zenchi) |
Free format text: JAPANESE INTERMEDIATE CODE: A911 Effective date: 20100906 |
|
| TRDD | Decision of grant or rejection written | ||
| A01 | Written decision to grant a patent or to grant a registration (utility model) |
Free format text: JAPANESE INTERMEDIATE CODE: A01 Effective date: 20110113 |
|
| A01 | Written decision to grant a patent or to grant a registration (utility model) |
Free format text: JAPANESE INTERMEDIATE CODE: A01 |
|
| A61 | First payment of annual fees (during grant procedure) |
Free format text: JAPANESE INTERMEDIATE CODE: A61 Effective date: 20110119 |
|
| R150 | Certificate of patent or registration of utility model |
Free format text: JAPANESE INTERMEDIATE CODE: R150 Ref document number: 4672096 Country of ref document: JP Free format text: JAPANESE INTERMEDIATE CODE: R150 |
|
| FPAY | Renewal fee payment (event date is renewal date of database) |
Free format text: PAYMENT UNTIL: 20140128 Year of fee payment: 3 |
|
| R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
| R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
| R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
| R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
| R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
| LAPS | Cancellation because of no payment of annual fees |